RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sino Biopharmaceutical Stock

Sino Biopharmaceutical Dividend 2024

Sino Biopharmaceutical Dividend

0.08 CNY

Sino Biopharmaceutical Dividend yield

2.13 %

Ticker

1177.HK

ISIN

KYG8167W1380

WKN

A0CBDJ

How much dividend does Sino Biopharmaceutical 2024 pay?

According to the latest status from October 2024, Sino Biopharmaceutical paid a total of 0.08 CNY per share in dividends within the last 12 months. With the current Sino Biopharmaceutical price of 3.75 CNY, this corresponds to a dividend yield of 2.13 %. A dividend is paid times per year.

2.13 % Dividend Yield=
0.08 CNY Dividend
3.75 CNY Stock Price

Historical Sino Biopharmaceutical Dividends

A dividend is paid times per year. Last year, the payout months were July and November.

PaydateDividend
10/12/20240
10/10/20240.03
7/11/20240.03
11/4/20230.02
7/20/20230.06
10/6/20220.06
7/15/20220.04
10/13/20210.02
7/18/20210.02
1/11/20210.02
10/14/20200.02
7/12/20200.02
1/10/20200.02
10/12/20190.02
7/14/20190.02
1/5/20190.02
10/11/20180.02
7/4/20180.01
12/28/20170.02
10/12/20170.02
1
2
3
4

Sino Biopharmaceutical dividend history and estimates

In 2023, Sino Biopharmaceutical paid a dividend amounting to 0.08 CNY. Dividend means that Sino Biopharmaceutical distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Sino Biopharmaceutical provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Sino Biopharmaceutical’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Sino Biopharmaceutical's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Sino Biopharmaceutical Dividend History

DateSino Biopharmaceutical Dividend
2029e0.08 undefined
2028e0.08 undefined
2027e0.08 undefined
2026e0.08 undefined
2025e0.08 undefined
2024e0.08 undefined
20230.08 undefined
20220.1 undefined
20210.04 undefined
20200.05 undefined
20190.04 undefined
20180.04 undefined
20170.03 undefined
20160.03 undefined
20150.02 undefined
20140.02 undefined
20130.01 undefined
20120.01 undefined
20110.02 undefined
20100.02 undefined
20090.01 undefined
20080.01 undefined
20070.01 undefined
20060.01 undefined
20050.02 undefined
20040 undefined

Is the Sino Biopharmaceutical Dividend Safe?

Sino Biopharmaceutical has been increasing the dividend for 2 years.

Over the past 10 years, Sino Biopharmaceutical has increased it by an annual 18.369 %.

Over a five-year period, the distribution increased by 17.601%.

Analysts expect a Dividend Increase of 2.509% for the current fiscal year.

Sino Biopharmaceutical dividend payout ratio

In 2023, Sino Biopharmaceutical had a payout ratio of 39.48%. The payout ratio indicates the percentage of the company's profits that Sino Biopharmaceutical distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Sino Biopharmaceutical represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Sino Biopharmaceutical could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Sino Biopharmaceutical's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Sino Biopharmaceutical Payout Ratio History

DateSino Biopharmaceutical Payout ratio
2029e45.73 %
2028e47.38 %
2027e45.68 %
2026e44.13 %
2025e52.33 %
2024e40.58 %
202339.48 %
202276.92 %
20215.33 %
202036.18 %
201927.25 %
20187.29 %
201723.9 %
201627.16 %
201514.09 %
201416.01 %
201321.16 %
201216.93 %
201179.01 %
201047.41 %
200937.04 %
200829.63 %
200744.44 %
200666.67 %
200511.57 %
200422.22 %

Dividend Details

Understanding Sino Biopharmaceutical's Dividend Distributions

Sino Biopharmaceutical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Sino Biopharmaceutical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Sino Biopharmaceutical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Sino Biopharmaceutical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Sino Biopharmaceutical Aktienanalyse

What does Sino Biopharmaceutical do?

Sino Biopharmaceutical Ltd is a leading biopharmaceutical company in China that focuses on research, development, production, and distribution of medications. The company is headquartered in Hong Kong and is listed on the Hong Kong Stock Exchange. The company was founded in 2000 by Dr. Tse Ping, an experienced entrepreneur in the chemical industry. The goal was to develop innovative medications that could improve people's health and lives. Since then, Sino Biopharmaceutical has become a major player in the pharmaceutical industry. Sino Biopharmaceutical's business model is based on three pillars: generics, innovative medications, and contract manufacturing. The company specializes in the development and production of generics to make affordable, high-quality medications accessible to the masses. At the same time, the company also invests in research and development of innovative medications for rare and serious diseases. Additionally, Sino Biopharmaceutical also offers contract manufacturing services to other companies. Sino Biopharmaceutical operates in four divisions: pharmaceutical manufacturing, research and development of biopharmaceutical medications, contract manufacturing, and sales and marketing activities. Pharmaceutical manufacturing includes the production of generics as well as the manufacturing of medications for specific indications. Research and development of biopharmaceutical medications focuses on the development of therapies for severe and rare diseases. Contract manufacturing involves the manufacturing process from raw material sourcing to packaging medications for other companies. Sales and marketing activities involve positioning and promoting Sino Biopharmaceutical's products in the market. Some of Sino Biopharmaceutical's well-known products include Hengrui Medicine, an anticancer medication used to treat cancer; Yigu, a medication for liver diseases; and Tongbi, a medication for osteoporosis. Sino Biopharmaceutical has a strong presence in the Chinese market, as well as the international market. The company exports its products to over 60 countries worldwide. Sino Biopharmaceutical has also become a key partner for international companies and regularly collaborates with other pharmaceutical corporations to expand their expertise in product development and manufacturing. In summary, Sino Biopharmaceutical Ltd is a major player in the pharmaceutical industry that specializes in the development and production of generics and innovative medications. There is also a focus on contract manufacturing of medications for other companies. The company has a strong presence in the Chinese market and exports its products to over 60 countries. Sino Biopharmaceutical is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Sino Biopharmaceutical stock

How much dividend does Sino Biopharmaceutical pay?

Over the past 12 months, Sino Biopharmaceutical paid a dividend of 0.08 CNY . This corresponds to a dividend yield of about 2.13 %. For the coming 12 months, Sino Biopharmaceutical is expected to pay a dividend of 0.08 CNY.

What is the dividend yield of Sino Biopharmaceutical?

The current dividend yield of Sino Biopharmaceutical is 2.13 %.

When does Sino Biopharmaceutical pay dividends?

Sino Biopharmaceutical pays a quarterly dividend. This is distributed in the months of November, July, October, October.

How secure is the dividend of Sino Biopharmaceutical?

Sino Biopharmaceutical paid dividends every year for the past 26 years.

What is the dividend of Sino Biopharmaceutical?

For the upcoming 12 months, dividends amounting to 0.08 CNY are expected. This corresponds to a dividend yield of 2.22 %.

In which sector is Sino Biopharmaceutical located?

Sino Biopharmaceutical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sino Biopharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sino Biopharmaceutical from 10/4/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did Sino Biopharmaceutical pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Sino Biopharmaceutical in the year 2023?

In the year 2023, Sino Biopharmaceutical distributed 0.1 CNY as dividends.

In which currency does Sino Biopharmaceutical pay out the dividend?

The dividends of Sino Biopharmaceutical are distributed in CNY.

Andere Kennzahlen von Sino Biopharmaceutical

Our stock analysis for Sino Biopharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sino Biopharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.